on August 9, 2007
Published online before print August 9, 2007, doi: 10.1161/ATVBAHA.107.142505
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on February 20, 2007
Accepted on July 23, 2007
Ubiquitin Carboxyl-Terminal Hydrolase L1, a Novel Deubiquitinating Enzyme in the Vasculature, Attenuates NF-
B Activation
Yoichi Takami ;
From the Department of Geriatric Medicine (Y.T., T.K., Y.B., O.Y., H.R., T.O.), Osaka University Graduate School of Medicine, Japan; the Division of Gene Therapy Science (Y.T., H.N., Y.S., H.H., Y.K., T.N., Y.K.), Osaka University Graduate School of Medicine, Japan; the Division of Clinical Gene Therapy (R.M.), Osaka University Graduate School of Medicine, Japan; and Cardiovascular Medicine (T.-X.C., T.I.), University of Michigan Medical Center, Ann Arbor.
* To whom correspondence should be addressed. E-mail: nakagami{at}gts.med.osaka-u.ac.jp.
Objective—We identified a ubiquitin carboxyl-terminal hydrolase L1 (UCHL1) gene, which encodes a deubiquitinating enzyme and is expressed in the vasculature, by functional screening of a human endothelial cell (EC) cDNA library. UCHL1 is expressed in neurons, and abnormalities in UCHL1 are responsible for inherited Parkinson’s disease via its effects on the ubiquitin-proteasome system. Therefore, the goal of present study was to clarify the role of the UCHL1 gene in vascular remodeling by evaluating nuclear factor-
B (NF-B) inactivation in ECs and vascular smooth muscle cells (VSMCs).
Methods and Results—From Northern blot and immunohistochemical analysis, the UCHL1 gene was endogenously expressed in vascular ECs, VSMCs, and brain tissue. Expression of UCHL1 was markedly increased in the neointima of the balloon-injured carotid artery and was also present in atherosclerotic lesions from human carotid arteries. Overexpression of the UCHL1 gene significantly attenuated tumor necrosis factor (TNF)-
–induced NF-B activity in vascular cells and increased inhibitor of kappa B- (IB-), possibly through the attenuation of IB- ubiquitination, leading to decreased neointima in the balloon-injured artery. In contrast, knockdown of UCHL1 by small interfering RNA resulted in increased NF-B activity in VSMCs.
Conclusions—These data suggest that UCHL1 may partially attenuate vascular remodeling through inhibition of NF-B activity.
Key words: UCHL1 • NF-
B •
deubiquitinating enzyme •
atherosclerosis
This article has been cited by other articles:
 |
|
 |
|
  J. Herrmann, L. O. Lerman, and A. Lerman On to the road to degradation: atherosclerosis and the proteasome Cardiovasc Res, November 14, 2009; (2009) cvp333v2. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Fasanaro, M. C. Capogrossi, and F. Martelli Regulation of the endothelial cell cycle by the ubiquitin-proteasome system Cardiovasc Res, August 7, 2009; (2009) cvp244v2. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Hayashi, H. Nakagami, Y. Takami, H. Koriyama, M. Mori, K. Tamai, J. Sun, K. Nagao, R. Morishita, and Y. Kaneda FHL-2 Suppresses VEGF-Induced Phosphatidylinositol 3-Kinase/Akt Activation via Interaction With Sphingosine Kinase-1 Arterioscler Thromb Vasc Biol, June 1, 2009; 29(6): 909 - 914. [Abstract] [Full Text] [PDF]
|
|